{"id":2503,"date":"2024-04-18T10:40:43","date_gmt":"2024-04-18T10:40:43","guid":{"rendered":"https:\/\/savior.sagetheme.com\/demo27\/?page_id=2503"},"modified":"2026-07-19T11:02:33","modified_gmt":"2026-07-19T11:02:33","slug":"veelbelovende-behandelingen","status":"publish","type":"page","link":"https:\/\/stichtingmuk.nl\/index.php\/veelbelovende-behandelingen\/","title":{"rendered":"De behandelingen"},"content":{"rendered":"\r\n<div class=\"sg-row sg-container sg-element container container-contained\" data-eq=\"1783950964216\">\r\n\t\t\r\n\t<div class=\"row-inner container-inner element-inner\">\r\n\t\t<div class=\"row-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t<div class=\"row-content container-content element-content\">\r\n\t\t\t\t\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964217\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\r\n<div class=\"sg-heading sg-element\" data-eq=\"1783950964218\">\r\n\t\t\r\n\t<div class=\"heading-inner element-inner\">\r\n\t\t<div class=\"heading-wrap element-wrap\">\r\n\t\t\t<div class=\"heading-content element-content\">\r\n\t\t\t\t\t\t\t\t\t<div class=\"subtitle typeset-170945773470\">Behandelingen in ontwikkeling<\/div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t<h1 class=\"title typeset-170945773471\">Hoop, met zorgvuldige verwachtingen<\/h1>\t\t\t\t\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-text-block sg-element\" data-eq=\"1783950964219\">\r\n\t\t\r\n\t<div class=\"text-inner element-inner\">\r\n\t\t<div class=\"text-wrap element-wrap\">\r\n\t\t\t<div class=\"text-content element-content\">\r\n\t\t\t\t<p>Voor Sanfilippo type A bestaat momenteel geen goedgekeurde behandeling die de ziekte kan stoppen. Wel worden meerdere therapie\u00ebn onderzocht. UX111 is het verst in het Amerikaanse beoordelingstraject; DNL126 bevindt zich in klinisch onderzoek.<\/p>\n<p>UX111 bevindt zich in een vergevorderde FDA-beoordelingsfase; DNL126 bevindt zich in klinisch onderzoek. Beide behandelingen zijn nog niet goedgekeurd, maar de fase waarin zij zich bevinden verschilt. De onderzoeksresultaten geven reden voor hoop, zonder een bepaald resultaat voor Muk te kunnen beloven.<\/p>\n<p><strong>Hieronder staat de actuele situatie, gecontroleerd op 16 juli 2026.<\/strong><\/p>\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-row sg-container sg-element container container-contained\" data-eq=\"1783950964220\">\r\n\t\t\r\n\t<div class=\"row-inner container-inner element-inner\">\r\n\t\t<div class=\"row-wrap container-wrap element-wrap\">\r\n\t\t\t<span class=\"ui-background ui-decor\"><\/span>\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t<div class=\"row-content container-content element-content\">\r\n\t\t\t\t\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964221\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\r\n<div class=\"sg-highlight-text sg-element\" data-settings=\"{&quot;strings&quot;:[&quot;Bigger&quot;,&quot;Bolder&quot;,&quot;Animated&quot;]}\" data-eq=\"1783950964222\">\r\n\t\t\r\n\t<div class=\"highlight-inner element-inner\">\r\n\t\t<div class=\"highlight-wrap element-wrap\">\r\n\t\t\t<div class=\"highlight-content element-content\">\r\n\t\t\t\t\t\t\t\t\t<div class=\"subtitle \">UX111<\/div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"title \">Gentherapie van Ultragenyx<\/h2>\t\t\t\t\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-text-block sg-element\" data-eq=\"1783950964223\">\r\n\t\t\r\n\t<div class=\"text-inner element-inner\">\r\n\t\t<div class=\"text-wrap element-wrap\">\r\n\t\t\t<div class=\"text-content element-content\">\r\n\t\t\t\t<p><strong>Wat is het?<\/strong><br \/>UX111 (rebisufligene etisparvovec) is een eenmalige AAV9-gentherapie. De behandeling is ontworpen om een werkende versie van het SGSH-gen naar de hersenen en andere organen te brengen, zodat het lichaam het ontbrekende enzym kan aanmaken.<\/p>\n<p><strong>Wat is de status?<\/strong><br \/>De FDA heeft de opnieuw ingediende aanvraag voor versnelde goedkeuring geaccepteerd en 19 september 2026 vastgesteld als actiedatum. Die datum is een beslismoment, geen toezegging dat de behandeling wordt goedgekeurd.<\/p>\n<p>UX111 is gebaseerd op vele jaren onderzoek. Ultragenyx rapporteert klinische gegevens met maximaal <strong>8,5 jaar follow-up<\/strong>, duurzame verbeteringen in biomarkers, betekenisvolle functionele voordelen ten opzichte van het natuurlijke ziekteverloop en een gunstig veiligheidsprofiel.<\/p>\n<p>De FDA-brief van juli 2025 ging over specifieke punten rond chemie, productie, kwaliteitscontrole, validatie en fabrieksinspecties. Ultragenyx meldde daarbij dat de FDA geen beoordelingsproblemen met het klinische datapakket of de klinische inspecties had genoemd. De aangepaste aanvraag is opnieuw ingediend en door de FDA voor beoordeling geaccepteerd.<\/p>\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-text-block sg-element\" data-eq=\"1784042000100\">\r\n\t\t\r\n\t<div class=\"text-inner element-inner\">\r\n\t\t<div class=\"text-wrap element-wrap\">\r\n\t\t\t<div class=\"text-content element-content\">\r\n\t\t\t\t<details class=\"muk-ux111-source\">\n<summary>Bronnen over UX111 en de onderzoeksresultaten<\/summary>\n<div class=\"muk-ux111-source__body\">\n<p>Stichting Sanfilippo Fonds vat de gerapporteerde langetermijngegevens samen en verwijst naar de onderstaande achterliggende bronnen.<\/p>\n<ul>\n<li><a href=\"https:\/\/sanfilippofonds.nl\/over-sanfilippo.html#ux111\" target=\"_blank\" rel=\"noopener noreferrer\">Stichting Sanfilippo Fonds: uitleg over UX111<\/a><\/li>\n<li><a href=\"https:\/\/ir.ultragenyx.com\/news-releases\/news-release-details\/ultragenyx-announces-positive-longer-term-data-demonstrating\" target=\"_blank\" rel=\"noopener noreferrer\">Ultragenyx: langeretermijngegevens van UX111<\/a><\/li>\n<li><a href=\"https:\/\/ir.ultragenyx.com\/news-releases\/news-release-details\/ultragenyx-announces-us-fda-acceptance-bla-resubmission-ux111\" target=\"_blank\" rel=\"noopener noreferrer\">Ultragenyx: FDA accepteert de hernieuwde aanvraag<\/a><\/li>\n<li><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT02716246\" target=\"_blank\" rel=\"noopener noreferrer\">ClinicalTrials.gov: Transpher A-studie<\/a><\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17206939\/\" target=\"_blank\" rel=\"noopener noreferrer\">PubMed: preklinisch AAV-SGSH-onderzoek<\/a><\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/paediatric-investigation-plans\/emea-002206-pip02-19\" target=\"_blank\" rel=\"noopener noreferrer\">EMA: Europees onderzoeks- en ontwikkeltraject<\/a><\/li>\n<\/ul>\n<\/div>\n<\/details>\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964224\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\r\n<div class=\"sg-highlight-text sg-element\" data-settings=\"{&quot;strings&quot;:[&quot;Bigger&quot;,&quot;Bolder&quot;,&quot;Animated&quot;]}\" data-eq=\"1783950964225\">\r\n\t\t\r\n\t<div class=\"highlight-inner element-inner\">\r\n\t\t<div class=\"highlight-wrap element-wrap\">\r\n\t\t\t<div class=\"highlight-content element-content\">\r\n\t\t\t\t\t\t\t\t\t<div class=\"subtitle \">DNL126<\/div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"title \">Enzymtherapie van Denali Therapeutics<\/h2>\t\t\t\t\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-text-block sg-element\" data-eq=\"1783950964226\">\r\n\t\t\r\n\t<div class=\"text-inner element-inner\">\r\n\t\t<div class=\"text-wrap element-wrap\">\r\n\t\t\t<div class=\"text-content element-content\">\r\n\t\t\t\t<p><strong>Wat is het?<\/strong><br \/>DNL126 is een experimentele enzymtherapie die via een infuus wordt toegediend. De gebruikte TransportVehicle-technologie is ontworpen om het SGSH-enzym ook over de bloed-hersenbarri\u00e8re te brengen.<\/p>\n<p><strong>Wat is de status?<\/strong><br \/>De fase 1\/2-studie met twintig deelnemers is volledig ingeschreven en loopt door. Denali meldde voorlopige veranderingen in ziektebiomarkers en bereidt een bevestigende fase 3-studie voor.<\/p>\n<p>Denali verwacht in 2027 mogelijk een Amerikaanse aanvraag en versnelde goedkeuringsroute. Dat is een planning van het bedrijf, geen vastgestelde FDA-beslisdatum en geen garantie op goedkeuring.<\/p>\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-row sg-container sg-element container container-contained\" data-eq=\"1783950964227\">\r\n\t\t\r\n\t<div class=\"row-inner container-inner element-inner\">\r\n\t\t<div class=\"row-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t<div class=\"row-content container-content element-content\">\r\n\t\t\t\t\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964228\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\r\n<div class=\"sg-highlight-text sg-element\" data-settings=\"{&quot;strings&quot;:[&quot;Bigger&quot;,&quot;Bolder&quot;,&quot;Animated&quot;]}\" data-eq=\"1783950964229\">\r\n\t\t\r\n\t<div class=\"highlight-inner element-inner\">\r\n\t\t<div class=\"highlight-wrap element-wrap\">\r\n\t\t\t<div class=\"highlight-content element-content\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"title \">Waarom we nu voorbereidingen treffen<\/h2>\t\t\t\t\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-text-block sg-element\" data-eq=\"1783950964230\">\r\n\t\t\r\n\t<div class=\"text-inner element-inner\">\r\n\t\t<div class=\"text-wrap element-wrap\">\r\n\t\t\t<div class=\"text-content element-content\">\r\n\t\t\t\t<p>Sanfilippo is progressief en de ontstane schade is onomkeerbaar. Niemand kan nu beloven of en wanneer Muk behandeld kan worden. Wel weten we dat wachten met fondsenwerving kostbare voorbereidingstijd zou verliezen.<\/p>\n<p>Door het doelbedrag vooraf bijeen te brengen, kan Stichting Muk sneller handelen als goedkeuring, medische beoordeling en beschikbaarheid samenkomen. Die voorbereiding geeft geen garantie, maar vergroot wel de mogelijkheid om een kans te benutten zodra die er is.<\/p>\n<p>Wij delen nieuwe informatie wanneer die officieel bevestigd is en passen deze pagina daarop aan.<\/p>\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-row sg-container sg-element container container-contained\" data-eq=\"1783950964231\">\r\n\t\t\r\n\t<div class=\"row-inner container-inner element-inner\">\r\n\t\t<div class=\"row-wrap container-wrap element-wrap\">\r\n\t\t\t<span class=\"ui-background ui-decor\"><\/span>\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t<div class=\"row-content container-content element-content\">\r\n\t\t\t\t\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964232\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\r\n<div class=\"sg-highlight-text sg-element\" data-settings=\"{&quot;strings&quot;:[&quot;Bigger&quot;,&quot;Bolder&quot;,&quot;Animated&quot;]}\" data-eq=\"1783950964233\">\r\n\t\t\r\n\t<div class=\"highlight-inner element-inner\">\r\n\t\t<div class=\"highlight-wrap element-wrap\">\r\n\t\t\t<div class=\"highlight-content element-content\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"title \">Wat we voor Muk hopen te winnen<\/h2>\t\t\t\t\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-text-block sg-element\" data-eq=\"1783950964234\">\r\n\t\t\r\n\t<div class=\"text-inner element-inner\">\r\n\t\t<div class=\"text-wrap element-wrap\">\r\n\t\t\t<div class=\"text-content element-content\">\r\n\t\t\t\t<p>Een behandeling kan mogelijk helpen om achteruitgang af te remmen en belangrijke vaardigheden langer te behouden. Hoe een individueel kind reageert, is niet vooraf te voorspellen. Onze hoop is gericht op:<\/p>\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-icon sg-element\" data-eq=\"1783950964235\">\r\n\t\t\r\n\t<div class=\"icon-inner element-inner\">\r\n\t\t<div class=\"icon-wrap element-wrap\">\r\n\t\t\t<div class=\"icon-content element-content\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t<span class=\"ui-icon ui-icn \">\r\n\t\t\t\t\t<span class=\"icn-inner\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<span class=\"icn-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"icn-primary\"><i class=\"icon icon-savior-love2\"><\/i><\/span>\r\n\t\t\t\t\t\t\t\t<span class=\"icn-secondary\"><i class=\"icon icon-savior-love2\"><\/i><\/span>\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\r\n\t\t\t\t\t<\/span>\r\n\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"icn-txt \">\r\n\t\t\t\t\t\t\tBelangrijke functies langer behouden\t\t\t\t\t\t<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/span>\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-icon sg-element\" data-eq=\"1783950964236\">\r\n\t\t\r\n\t<div class=\"icon-inner element-inner\">\r\n\t\t<div class=\"icon-wrap element-wrap\">\r\n\t\t\t<div class=\"icon-content element-content\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t<span class=\"ui-icon ui-icn \">\r\n\t\t\t\t\t<span class=\"icn-inner\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<span class=\"icn-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"icn-primary\"><i class=\"icon icon-savior-love2\"><\/i><\/span>\r\n\t\t\t\t\t\t\t\t<span class=\"icn-secondary\"><i class=\"icon icon-savior-love2\"><\/i><\/span>\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\r\n\t\t\t\t\t<\/span>\r\n\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"icn-txt \">\r\n\t\t\t\t\t\t\tMeer tijd en kwaliteit van leven\t\t\t\t\t\t<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/span>\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-text-block sg-element\" data-eq=\"1783950964244\">\r\n\t\t\r\n\t<div class=\"text-inner element-inner\">\r\n\t\t<div class=\"text-wrap element-wrap\">\r\n\t\t\t<div class=\"text-content element-content\">\r\n\t\t\t\t<p><small><strong>Bronnen:<\/strong> <a href=\"https:\/\/ir.ultragenyx.com\/node\/17891\" target=\"_blank\" rel=\"noopener noreferrer\">Ultragenyx, FDA-brief en productiepunten, 11 juli 2025<\/a>; <a href=\"https:\/\/ir.ultragenyx.com\/news-releases\/news-release-details\/ultragenyx-announces-positive-longer-term-data-demonstrating\" target=\"_blank\" rel=\"noopener noreferrer\">Ultragenyx, klinische gegevens tot 8,5 jaar, 3 februari 2026<\/a>; <a href=\"https:\/\/ir.ultragenyx.com\/news-releases\/news-release-details\/ultragenyx-announces-us-fda-acceptance-bla-resubmission-ux111\" target=\"_blank\" rel=\"noopener noreferrer\">Ultragenyx, hernieuwde FDA-beoordeling, 2 april 2026<\/a>; <a href=\"https:\/\/investors.denalitherapeutics.com\/news-releases\/news-release-details\/denali-therapeutics-reports-first-quarter-2026-financial-results\" target=\"_blank\" rel=\"noopener noreferrer\">Denali Therapeutics, 7 mei 2026<\/a>; <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06181136\" target=\"_blank\" rel=\"noopener noreferrer\">ClinicalTrials.gov, DNL126-studie<\/a>.<\/small><\/p>\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-row sg-container sg-element container\" data-eq=\"1783950964237\">\r\n\t\t\r\n\t<div class=\"row-inner container-inner element-inner\">\r\n\t\t<div class=\"row-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t<div class=\"row-content container-content element-content\">\r\n\t\t\t\t\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964238\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\r\n<div class=\"sg-button sg-element style-rounded\" data-eq=\"1783950964239\">\r\n\t\t\r\n\t<div class=\"button-inner element-inner\">\r\n\t\t<div class=\"button-wrap element-wrap\">\r\n\t\t\t<div class=\"button-content element-content\">\r\n\t\t\t\t<a class=\"ui-btn has-secondary-text txAnim-slideInYFlow\" href=\"https:\/\/stichtingmuk.nl\/index.php\/steun-muk\/\">\t\t\t\t\r\n\t\t\t\t<span class=\"btn-inner\">\r\n\t\t\t\t\t<span class=\"ui-background ui-decor\"><\/span>\t\t\t\t\t\r\n\t\t\t\t\t<span class=\"btn-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"btn-txt \">\r\n\t\t\t\t\t\t\t\t<span class=\"txt-primary\">Doneer nu<\/span>\r\n\t\t\t\t\t\t\t\t<span class=\"txt-secondary\">geef Muk een toekomst<\/span>\r\n\t\t\t\t\t\t\t<\/span>\r\n\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\r\n\t\t\t\t<\/span>\r\n\t\t\t\t\r\n\t\t\t\t<\/a>\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964240\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964241\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964242\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<div class=\"sg-column sg-container sg-element\" data-eq=\"1783950964243\">\r\n\t\t\r\n\t<div class=\"column-container container\">\r\n\t\t<div class=\"column-inner container-inner element-inner\">\r\n\t\t\t<div class=\"column-wrap container-wrap element-wrap\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t<div class=\"column-content container-content element-content\">\r\n\t\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"give_campaign_id":0,"footnotes":""},"class_list":["post-2503","page","type-page","status-publish","hentry"],"campaignId":"","_links":{"self":[{"href":"https:\/\/stichtingmuk.nl\/index.php\/wp-json\/wp\/v2\/pages\/2503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stichtingmuk.nl\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stichtingmuk.nl\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stichtingmuk.nl\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stichtingmuk.nl\/index.php\/wp-json\/wp\/v2\/comments?post=2503"}],"version-history":[{"count":64,"href":"https:\/\/stichtingmuk.nl\/index.php\/wp-json\/wp\/v2\/pages\/2503\/revisions"}],"predecessor-version":[{"id":32211,"href":"https:\/\/stichtingmuk.nl\/index.php\/wp-json\/wp\/v2\/pages\/2503\/revisions\/32211"}],"wp:attachment":[{"href":"https:\/\/stichtingmuk.nl\/index.php\/wp-json\/wp\/v2\/media?parent=2503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}